Practice Areas


Print PDF

Hatch-Waxman and BPCIA Essentials

Anne Maxwell, Ph.D. to speak on The Purple Book

October 14, 2021
virtual conference

Anne Maxwell, Ph.D., Esq., Chair of Cantor Colburn's Pharmaceutical Patent Services Practice, will speak on at the Hatch-Waxman and BPCIA Passport to Proficiency Series, a virtual three-week program designed to provide new lawyers and executives for the life sciences industry with a solid foundation for understanding the essentials as well as the intricacies of Hatch-Waxman and BPCIA litigation and regulation. Dr. Maxwell speak on The Purple Book, focusing on generic pharmaceuticals. 

Dr. Maxwell provides all aspects of patent representation to clients working in chemical and life science research with a particular emphasis on the pharmaceutical and agricultural chemical industries, and Chairs the firm's Pharmaceutical Patent Practice. She has more than 15 years’ experience drafting patent applications and prosecuting U.S. and non-U.S. patent applications in the areas of small molecule pharmaceuticals, drug delivery and formulations, biological therapeutics, chemical processes, medical diagnostics, biomaterials, and agricultural chemicals. She performs searches, determines patentability and freedom to operate, drafts and prosecutes patent applications, counsels clients in their development of effective patent protection worldwide, and assists clients with licensing and due diligence. She also prepares invalidity and non-infringement opinions and supports Cantor Colburn’s Litigation Department in Abbreviated New Drug Application litigation.

Anne Maxwell, Ph.D., Esq. Cantor Colburn LLP